Atria Investments LLC Pfizer Inc Transaction History

Atria Investments LLC

$7.56 Billion
Q3 2024

A detailed history of Atria Investments LLC transactions in Pfizer Inc stock. As of the latest transaction made, Atria Investments LLC holds 300,430 shares of PFE stock, worth $8.03 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

300,430

Previous 297,187 1.09%

Holding current value

$8.03 Million

Previous $8.32 Million 4.56%

% of portfolio

0.12%

Previous 0.11%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$27.7 - $31.39 $89,831 - $101,797	3,243 Added 1.09%	300,430 $8.69 Million
Q2 2024 Aug 13, 2024	BUY	$25.26 - $29.6 $566,127 - $663,395	22,412 Added 8.16%	297,187 $8.32 Million
Q1 2024 May 21, 2024	BUY	$25.89 - $29.73 $768,622 - $882,624	29,688 Added 12.11%	274,775 $7.63 Million
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $1.91 Million - $2.48 Million	-73,011 Reduced 22.95%	245,087 $7.06 Million
Q3 2023 Nov 07, 2023	BUY	$32.09 - $37.51 $878,688 - $1.03 Million	27,382 Added 9.42%	318,098 $10.6 Million
Q2 2023 Aug 04, 2023	BUY	$36.12 - $41.79 $3,539 - $4,095	98 Added 0.03%	290,716 $10.7 Million
Q1 2023 May 10, 2023	BUY	$39.39 - $51.28 $229,210 - $298,398	5,819 Added 2.04%	290,618 $11.9 Million
Q4 2022 Jan 31, 2023	BUY	$41.75 - $54.5 $1.98 Million - $2.58 Million	47,386 Added 19.96%	284,799 $14.6 Million
Q3 2022 Nov 01, 2022	SELL	$43.76 - $53.42 $882,682 - $1.08 Million	-20,171 Reduced 7.83%	237,413 $10.4 Million
Q2 2022 Aug 11, 2022	BUY	$46.53 - $55.17 $667,286 - $791,192	14,341 Added 5.9%	257,584 $13.5 Million
Q1 2022 May 02, 2022	BUY	$45.75 - $56.69 $1.08 Million - $1.34 Million	23,572 Added 10.73%	243,243 $12.6 Million
Q4 2021 Feb 04, 2022	SELL	$41.32 - $61.25 $157,759 - $233,852	-3,818 Reduced 1.71%	219,671 $13 Million
Q3 2021 Nov 16, 2021	SELL	$39.25 - $50.42 $206,219 - $264,906	-5,254 Reduced 2.3%	223,489 $9.61 Million
Q2 2021 Aug 10, 2021	BUY	$35.91 - $40.68 $542,851 - $614,959	15,117 Added 7.08%	228,743 $8.96 Million
Q1 2021 May 11, 2021	BUY	$33.49 - $37.77 $265,441 - $299,365	7,926 Added 3.85%	213,626 $7.74 Million
Q4 2020 Feb 12, 2021	SELL	$33.47 - $42.56 $913,664 - $1.16 Million	-27,298 Reduced 11.72%	205,700 $7.57 Million
Q3 2020 Nov 05, 2020	BUY	$31.75 - $37.25 $588,772 - $690,764	18,544 Added 8.65%	232,998 $8.55 Million
Q2 2020 Sep 22, 2020	BUY	$30.12 - $36.54 $6.46 Million - $7.84 Million	214,454 New	214,454 $7.01 Million
Q1 2020 May 15, 2020	SELL	$27.03 - $38.62 $9.55 Million - $13.6 Million	-353,223 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$32.92 - $37.36 $4.9 Million - $5.56 Million	148,891 Added 72.87%	353,223 $13.8 Million
Q3 2019 Nov 14, 2019	BUY	$32.49 - $42.13 $307,517 - $398,760	9,465 Added 4.86%	204,332 $7.34 Million
Q2 2019 Aug 26, 2019	BUY	$36.98 - $41.52 $7.21 Million - $8.09 Million	194,867 New	194,867 $6.79 Million
Q2 2019 Aug 09, 2019	SELL	$36.98 - $41.52 $5.55 Million - $6.23 Million	-150,046 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$37.5 - $41.2 $203,512 - $223,592	-5,427 Reduced 3.49%	150,046 $6.37 Million
Q4 2018 Feb 12, 2019	SELL	$38.47 - $43.86 $2.13 Million - $2.43 Million	-55,494 Reduced 26.3%	155,473 $6.79 Million
Q3 2018 Oct 09, 2018	SELL	$34.47 - $41.81 $250,700 - $304,084	-7,273 Reduced 3.33%	210,967 $9.3 Million
Q2 2018 Jul 13, 2018	SELL	$32.98 - $35.16 $403,477 - $430,147	-12,234 Reduced 5.31%	218,240 $7.92 Million
Q1 2018 Apr 30, 2018	SELL	$31.91 - $37.02 $131,979 - $153,114	-4,136 Reduced 1.76%	230,474 $8.18 Million
Q4 2017 Jan 16, 2018	BUY	$33.26 - $35.29 $855,713 - $907,941	25,728 Added 12.32%	234,610 $8.5 Million
Q3 2017 Oct 12, 2017	BUY	$31.0 - $34.15 $6.48 Million - $7.13 Million	208,882	208,882 $7.46 Million

Others Institutions Holding PFE

# of Institutions

3,257

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atria Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atria Investments LLC with notifications on news.

Account

Atria Investments LLC Pfizer Inc Transaction History